XML 37 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Share-based Compensation (Tables)
9 Months Ended
Oct. 03, 2021
Share-based Payment Arrangement [Abstract]  
Summary of Share Option Awards

A summary of the status of the Company’s share option awards is presented below:

 

 

 

Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life
(In Years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding at January 3, 2021

 

 

742,800

 

 

$

4.62

 

 

 

 

 

 

 

Exercised

 

 

(318,275

)

 

 

5.67

 

 

 

 

 

 

 

Outstanding at October 3, 2021

 

 

424,525

 

 

$

3.84

 

 

 

7.56

 

 

$

8,606,225

 

Exercisable at October 3, 2021

 

 

58,625

 

 

$

6.72

 

 

 

6.05

 

 

$

1,019,545

 

Vested and Expected to Vest at October 3, 2021

 

 

419,068

 

 

$

3.85

 

 

 

7.55

 

 

$

8,489,154

 

Weighted-Average Assumptions Used to Estimate the Fair Value of Each Share Option Award

The fair value of each share option award on the date of grant is estimated using the Black-Scholes method based on the following weighted-average assumptions:

 

 

 

13 Weeks Ended

 

 

39 Weeks Ended

 

 

 

October 3,
2021

 

 

September 27,
2020

 

 

October 3,
2021

 

 

September 27,
2020

 

Risk-free interest rate

 

 

 

 

 

 

 

 

 

 

 

0.9

%

Expected term

 

 

 

 

 

 

 

 

 

 

5.7 years

 

Expected volatility

 

 

 

 

 

 

 

 

 

 

 

63.0

%

Expected dividend yield

 

 

 

 

 

 

 

 

 

 

 

 

Summary of Nonvested Share Awards Activity

A summary of the status of the Company’s nonvested share awards is presented below:

 

 

 

Shares

 

 

Weighted-
Average Grant-
Date Fair
Value

 

Balance at January 3, 2021

 

 

591,325

 

 

$

3.79

 

Granted

 

 

248,550

 

 

 

15.61

 

Vested

 

 

(268,550

)

 

 

4.83

 

Forfeited

 

 

(15,655

)

 

 

6.16

 

Balance at October 3, 2021

 

 

555,670

 

 

$

8.51

 

A summary of the status of the Company’s nonvested share unit awards is presented below:

 

 

 

Units

 

 

Weighted-
Average Grant-
Date Fair
Value

 

Balance at January 3, 2021

 

 

41,160

 

 

$

1.91

 

Granted

 

 

2,614

 

 

 

28.69

 

Dividend reinvestments

 

 

14,841

 

 

 

27.46

 

Vested

 

 

(40,000

)

 

 

2.28

 

Dividend reinvestments vested

 

 

(15,975

)

 

 

25.98

 

Balance at October 3, 2021

 

 

2,640

 

 

$

20.86